UPDATE: Meridian Bioscience Announces Investment in Oasis Diagnostics; Terms Not Disclosed
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today
announced that it has made a minority investment in Oasis Diagnostics®
Corporation ("Oasis"), with the right to acquire Oasis in the future.
The terms of the transaction were not disclosed.
Oasis designs, develops, manufactures and sells pre-analytic tools for
the collection, preservation, and transportation of saliva/oral fluids.
Oasis' focus is to provide high-quality, innovative diagnostic solutions
based on non-invasive saliva-based technologies. Technologies developed
by Oasis serve various segments of the in vitro diagnostics market,
including molecular diagnostics, nucleic acid testing, point-of-care
testing, and laboratory-based testing. Founded in 2002 by Dr. Paul
Slowey, Oasis has developed a portfolio of proprietary and patented